Creative Realities Inc. (CREX)
Creative Realities Inc. (CREX) Stock Price, Analysis & Data
| Бид | 3.15 |
| Рыночная капитализация | 39.29M |
| Выручка (TTM) | 63.85M |
| Чистая прибыль (TTM) | -19.73M |
| Бета | 1.53 |
| EPS (TTM) | -1.87 |
| P/E (TTM) | n/a |
| Прогнозный P/E | 14.29 |
| P/B (TTM) | 2.43 |
| P/S (TTM) | 0.62 |
| Earnings Date | Aug 13, 2026 |
| Аск | 3.05 |
| Объём торгов | 26,974 |
| Ср. объём (20д) | 37,170 |
| Открытие | 3.03 |
| Пред. закрытие | 3.00 |
| Диапазон дня | 2.91 - 3.04 |
| Диапазон за 52 недели | 2.19 - 4.42 |
| Аналитики | n/a |
| Целевая цена | 7.5 (150.00%) |
| Дивиденды | n/a |
| Дата отсечки | n/a |
О компании CREX
Creative Realities, Inc., together with its subsidiaries, provides digital signage and media solutions in the United States and internationally. It resells digital signage hardware from original equipment manufacturers. The company also provides design, deployment, and management of digital signage and in-store retail media networks services, including hardware system design/engineering, hardware installation, content development, and post-develo...
Финансовые результаты
В 2025 году выручка Creative Realities составила 57.23M — это рост на 12.54% к прошлогодним 50.85M. Прибыль составила -8.28M — это рост на 135.92%.
Финансовая отчётностьПрогноз аналитиков
По 3 оценкам аналитиков средний рейтинг акций CREX — «null». Прогноз цены на 12 месяцев — 7.5, это потенциал роста на 150% от последней цены.
Прогнозы по акцииСюрприз в отчёте
Аналитики ждут выручку ... Улучшить тариф
2 месяцев назад · Simply Wall St.
How The Creative Realities (CREX) Story Is Shifting With New Targets And Theater PartnershipCreative Realities is back in focus after analysts revised their fair value price target from US$8.17 to US$8.83 per share. Bulls see this updated target as better aligned with their latest view of th...
3 месяцев назад · GuruFocus.com
Creative Realities Inc (CREX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic GrowthCreative Realities Inc (CREX) reports a significant revenue increase and strategic advancements following the CDM acquisition, despite challenges in legacy business and increased expenses.
